STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $790,000 | -1.2% | 73,870 | -0.0% | 0.00% | 0.0% |
Q3 2016 | $800,000 | +79.0% | 73,893 | +11.8% | 0.00% | 0.0% |
Q2 2016 | $447,000 | +64.3% | 66,093 | +13.1% | 0.00% | – |
Q1 2016 | $272,000 | -25.9% | 58,417 | +0.5% | 0.00% | – |
Q4 2015 | $367,000 | -28.3% | 58,127 | +0.3% | 0.00% | -100.0% |
Q3 2015 | $512,000 | -25.5% | 57,934 | -0.8% | 0.00% | 0.0% |
Q2 2015 | $687,000 | +10.1% | 58,402 | +35.4% | 0.00% | 0.0% |
Q1 2015 | $624,000 | +7.8% | 43,138 | +27.1% | 0.00% | 0.0% |
Q4 2014 | $579,000 | +36.6% | 33,943 | -0.3% | 0.00% | 0.0% |
Q3 2014 | $424,000 | -13.1% | 34,058 | +2.3% | 0.00% | 0.0% |
Q2 2014 | $488,000 | -10.8% | 33,289 | +23.9% | 0.00% | 0.0% |
Q1 2014 | $547,000 | +6.4% | 26,863 | +2.4% | 0.00% | 0.0% |
Q4 2013 | $514,000 | -56.2% | 26,232 | +1.2% | 0.00% | -50.0% |
Q3 2013 | $1,174,000 | +106.7% | 25,927 | +8.8% | 0.00% | +100.0% |
Q2 2013 | $568,000 | – | 23,828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |